<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1999-07-15" modified="2020-10-07" version="177">
<accession>O60880</accession>
<accession>A8MSW0</accession>
<accession>O95383</accession>
<accession>O95384</accession>
<accession>O95385</accession>
<accession>O95386</accession>
<accession>Q6FGS6</accession>
<accession>Q9UNR0</accession>
<name>SH21A_HUMAN</name>
<protein>
<recommendedName>
<fullName>SH2 domain-containing protein 1A</fullName>
</recommendedName>
<alternativeName>
<fullName>Duncan disease SH2-protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Signaling lymphocytic activation molecule-associated protein</fullName>
<shortName>SLAM-associated protein</shortName>
</alternativeName>
<alternativeName>
<fullName>T-cell signal transduction molecule SAP</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">SH2D1A</name>
<name type="synonym">DSHP</name>
<name type="synonym">SAP</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Nat. Genet." volume="20" first="129" last="135">
<title>Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene.</title>
<authorList>
<person name="Coffey A.J."/>
<person name="Brooksbank R.A."/>
<person name="Brandau O."/>
<person name="Oohashi T."/>
<person name="Howell G.R."/>
<person name="Bye J.M."/>
<person name="Cahn A.P."/>
<person name="Durham J."/>
<person name="Heath P."/>
<person name="Wray P."/>
<person name="Pavitt R."/>
<person name="Wilkinson J."/>
<person name="Leversha M."/>
<person name="Huckle E."/>
<person name="Shaw-Smith C.J."/>
<person name="Dunham A."/>
<person name="Rhodes S."/>
<person name="Schuster V."/>
<person name="Porta G."/>
<person name="Yin L."/>
<person name="Serafini P."/>
<person name="Sylla B."/>
<person name="Zollo M."/>
<person name="Franco B."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="9771704"/>
<dbReference type="DOI" id="10.1038/2424"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANTS XLP1 THR-32; ILE-68 AND LEU-101</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="Nature" volume="395" first="462" last="469">
<title>The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM.</title>
<authorList>
<person name="Sayos J."/>
<person name="Wu C."/>
<person name="Morra M."/>
<person name="Wang N."/>
<person name="Zhang X."/>
<person name="Allen D."/>
<person name="van Schaik S."/>
<person name="Notarangelo L."/>
<person name="Geha R."/>
<person name="Roncarolo M.G."/>
<person name="Oettgen H."/>
<person name="de Vries J.E."/>
<person name="Aversa G."/>
<person name="Terhorst C."/>
</authorList>
<dbReference type="PubMed" id="9774102"/>
<dbReference type="DOI" id="10.1038/26683"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2001" name="Int. Immunol." volume="13" first="559" last="565">
<title>Decreased expression of signaling lymphocytic-activation molecule-associated protein (SAP) transcripts in T cells from patients with rheumatoid arthritis.</title>
<authorList>
<person name="Takei M."/>
<person name="Ishiwata T."/>
<person name="Mitamura K."/>
<person name="Fujiwara S."/>
<person name="Sasaki K."/>
<person name="Nishi T."/>
<person name="Kuga T."/>
<person name="Ookubo T."/>
<person name="Horie T."/>
<person name="Ryu J."/>
<person name="Ohi H."/>
<person name="Sawada S."/>
</authorList>
<dbReference type="PubMed" id="11282995"/>
<dbReference type="DOI" id="10.1093/intimm/13.4.559"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="4">
<citation type="submission" date="1998-10" db="EMBL/GenBank/DDBJ databases">
<title>The Duncan's disease gene is preferentially expressed in lymphoid cell lineages and undergoes high levels of alternative splicing.</title>
<authorList>
<person name="Amemiya C.T."/>
<person name="Halevi A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2004-06" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201).</title>
<authorList>
<person name="Halleck A."/>
<person name="Ebert L."/>
<person name="Mkoundinya M."/>
<person name="Schick M."/>
<person name="Eisenstein S."/>
<person name="Neubert P."/>
<person name="Kstrang K."/>
<person name="Schatten R."/>
<person name="Shen B."/>
<person name="Henze S."/>
<person name="Mar W."/>
<person name="Korn B."/>
<person name="Zuo D."/>
<person name="Hu Y."/>
<person name="LaBaer J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2005" name="Nature" volume="434" first="325" last="337">
<title>The DNA sequence of the human X chromosome.</title>
<authorList>
<person name="Ross M.T."/>
<person name="Grafham D.V."/>
<person name="Coffey A.J."/>
<person name="Scherer S."/>
<person name="McLay K."/>
<person name="Muzny D."/>
<person name="Platzer M."/>
<person name="Howell G.R."/>
<person name="Burrows C."/>
<person name="Bird C.P."/>
<person name="Frankish A."/>
<person name="Lovell F.L."/>
<person name="Howe K.L."/>
<person name="Ashurst J.L."/>
<person name="Fulton R.S."/>
<person name="Sudbrak R."/>
<person name="Wen G."/>
<person name="Jones M.C."/>
<person name="Hurles M.E."/>
<person name="Andrews T.D."/>
<person name="Scott C.E."/>
<person name="Searle S."/>
<person name="Ramser J."/>
<person name="Whittaker A."/>
<person name="Deadman R."/>
<person name="Carter N.P."/>
<person name="Hunt S.E."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Gunaratne P."/>
<person name="Havlak P."/>
<person name="Hodgson A."/>
<person name="Metzker M.L."/>
<person name="Richards S."/>
<person name="Scott G."/>
<person name="Steffen D."/>
<person name="Sodergren E."/>
<person name="Wheeler D.A."/>
<person name="Worley K.C."/>
<person name="Ainscough R."/>
<person name="Ambrose K.D."/>
<person name="Ansari-Lari M.A."/>
<person name="Aradhya S."/>
<person name="Ashwell R.I."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Ballabio A."/>
<person name="Banerjee R."/>
<person name="Barker G.E."/>
<person name="Barlow K.F."/>
<person name="Barrett I.P."/>
<person name="Bates K.N."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Beck A."/>
<person name="Bethel G."/>
<person name="Blechschmidt K."/>
<person name="Brady N."/>
<person name="Bray-Allen S."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Brown M.J."/>
<person name="Bonnin D."/>
<person name="Bruford E.A."/>
<person name="Buhay C."/>
<person name="Burch P."/>
<person name="Burford D."/>
<person name="Burgess J."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Bye J.M."/>
<person name="Carder C."/>
<person name="Carrel L."/>
<person name="Chako J."/>
<person name="Chapman J.C."/>
<person name="Chavez D."/>
<person name="Chen E."/>
<person name="Chen G."/>
<person name="Chen Y."/>
<person name="Chen Z."/>
<person name="Chinault C."/>
<person name="Ciccodicola A."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Clerc-Blankenburg K."/>
<person name="Clifford K."/>
<person name="Cobley V."/>
<person name="Cole C.G."/>
<person name="Conquer J.S."/>
<person name="Corby N."/>
<person name="Connor R.E."/>
<person name="David R."/>
<person name="Davies J."/>
<person name="Davis C."/>
<person name="Davis J."/>
<person name="Delgado O."/>
<person name="Deshazo D."/>
<person name="Dhami P."/>
<person name="Ding Y."/>
<person name="Dinh H."/>
<person name="Dodsworth S."/>
<person name="Draper H."/>
<person name="Dugan-Rocha S."/>
<person name="Dunham A."/>
<person name="Dunn M."/>
<person name="Durbin K.J."/>
<person name="Dutta I."/>
<person name="Eades T."/>
<person name="Ellwood M."/>
<person name="Emery-Cohen A."/>
<person name="Errington H."/>
<person name="Evans K.L."/>
<person name="Faulkner L."/>
<person name="Francis F."/>
<person name="Frankland J."/>
<person name="Fraser A.E."/>
<person name="Galgoczy P."/>
<person name="Gilbert J."/>
<person name="Gill R."/>
<person name="Gloeckner G."/>
<person name="Gregory S.G."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gu Y."/>
<person name="Gwilliam R."/>
<person name="Hamilton C."/>
<person name="Hart E.A."/>
<person name="Hawes A."/>
<person name="Heath P.D."/>
<person name="Heitmann K."/>
<person name="Hennig S."/>
<person name="Hernandez J."/>
<person name="Hinzmann B."/>
<person name="Ho S."/>
<person name="Hoffs M."/>
<person name="Howden P.J."/>
<person name="Huckle E.J."/>
<person name="Hume J."/>
<person name="Hunt P.J."/>
<person name="Hunt A.R."/>
<person name="Isherwood J."/>
<person name="Jacob L."/>
<person name="Johnson D."/>
<person name="Jones S."/>
<person name="de Jong P.J."/>
<person name="Joseph S.S."/>
<person name="Keenan S."/>
<person name="Kelly S."/>
<person name="Kershaw J.K."/>
<person name="Khan Z."/>
<person name="Kioschis P."/>
<person name="Klages S."/>
<person name="Knights A.J."/>
<person name="Kosiura A."/>
<person name="Kovar-Smith C."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leversha M."/>
<person name="Lewis L."/>
<person name="Liu W."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loulseged H."/>
<person name="Loveland J.E."/>
<person name="Lovell J.D."/>
<person name="Lozado R."/>
<person name="Lu J."/>
<person name="Lyne R."/>
<person name="Ma J."/>
<person name="Maheshwari M."/>
<person name="Matthews L.H."/>
<person name="McDowall J."/>
<person name="McLaren S."/>
<person name="McMurray A."/>
<person name="Meidl P."/>
<person name="Meitinger T."/>
<person name="Milne S."/>
<person name="Miner G."/>
<person name="Mistry S.L."/>
<person name="Morgan M."/>
<person name="Morris S."/>
<person name="Mueller I."/>
<person name="Mullikin J.C."/>
<person name="Nguyen N."/>
<person name="Nordsiek G."/>
<person name="Nyakatura G."/>
<person name="O'dell C.N."/>
<person name="Okwuonu G."/>
<person name="Palmer S."/>
<person name="Pandian R."/>
<person name="Parker D."/>
<person name="Parrish J."/>
<person name="Pasternak S."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Pearson D.M."/>
<person name="Pelan S.E."/>
<person name="Perez L."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Reichwald K."/>
<person name="Rhodes S."/>
<person name="Ridler K.A."/>
<person name="Schlessinger D."/>
<person name="Schueler M.G."/>
<person name="Sehra H.K."/>
<person name="Shaw-Smith C."/>
<person name="Shen H."/>
<person name="Sheridan E.M."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Sotheran E.C."/>
<person name="Steingruber H.E."/>
<person name="Steward C.A."/>
<person name="Storey R."/>
<person name="Swann R.M."/>
<person name="Swarbreck D."/>
<person name="Tabor P.E."/>
<person name="Taudien S."/>
<person name="Taylor T."/>
<person name="Teague B."/>
<person name="Thomas K."/>
<person name="Thorpe A."/>
<person name="Timms K."/>
<person name="Tracey A."/>
<person name="Trevanion S."/>
<person name="Tromans A.C."/>
<person name="d'Urso M."/>
<person name="Verduzco D."/>
<person name="Villasana D."/>
<person name="Waldron L."/>
<person name="Wall M."/>
<person name="Wang Q."/>
<person name="Warren J."/>
<person name="Warry G.L."/>
<person name="Wei X."/>
<person name="West A."/>
<person name="Whitehead S.L."/>
<person name="Whiteley M.N."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams G."/>
<person name="Williams L."/>
<person name="Williamson A."/>
<person name="Williamson H."/>
<person name="Wilming L."/>
<person name="Woodmansey R.L."/>
<person name="Wray P.W."/>
<person name="Yen J."/>
<person name="Zhang J."/>
<person name="Zhou J."/>
<person name="Zoghbi H."/>
<person name="Zorilla S."/>
<person name="Buck D."/>
<person name="Reinhardt R."/>
<person name="Poustka A."/>
<person name="Rosenthal A."/>
<person name="Lehrach H."/>
<person name="Meindl A."/>
<person name="Minx P.J."/>
<person name="Hillier L.W."/>
<person name="Willard H.F."/>
<person name="Wilson R.K."/>
<person name="Waterston R.H."/>
<person name="Rice C.M."/>
<person name="Vaudin M."/>
<person name="Coulson A."/>
<person name="Nelson D.L."/>
<person name="Weinstock G."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Gibbs R.A."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="15772651"/>
<dbReference type="DOI" id="10.1038/nature03440"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A)</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2001" name="Blood" volume="97" first="3867" last="3874">
<title>Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP.</title>
<authorList>
<person name="Sayos J."/>
<person name="Martin M."/>
<person name="Chen A."/>
<person name="Simarro M."/>
<person name="Howie D."/>
<person name="Morra M."/>
<person name="Engel P."/>
<person name="Terhorst C."/>
</authorList>
<dbReference type="PubMed" id="11389028"/>
<dbReference type="DOI" id="10.1182/blood.v97.12.3867"/>
</citation>
<scope>INTERACTION WITH CD84</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="Blood" volume="99" first="957" last="965">
<title>Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation.</title>
<authorList>
<person name="Howie D."/>
<person name="Simarro M."/>
<person name="Sayos J."/>
<person name="Guirado M."/>
<person name="Sancho J."/>
<person name="Terhorst C."/>
</authorList>
<dbReference type="PubMed" id="11806999"/>
<dbReference type="DOI" id="10.1182/blood.v99.3.957"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SLAMF1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="Eur. J. Immunol." volume="32" first="1640" last="1649">
<title>CD84 is up-regulated on a major population of human memory B cells and recruits the SH2 domain containing proteins SAP and EAT-2.</title>
<authorList>
<person name="Tangye S.G."/>
<person name="van de Weerdt B.C.M."/>
<person name="Avery D.T."/>
<person name="Hodgkin P.D."/>
</authorList>
<dbReference type="PubMed" id="12115647"/>
<dbReference type="DOI" id="10.1002/1521-4141(200206)32:6&lt;1640::aid-immu1640&gt;3.0.co;2-s"/>
</citation>
<scope>INTERACTION WITH CD84</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="3852" last="3859">
<title>Dual functional roles for the X-linked lymphoproliferative syndrome gene product SAP/SH2D1A in signaling through the signaling lymphocyte activation molecule (SLAM) family of immune receptors.</title>
<authorList>
<person name="Li C."/>
<person name="Iosef C."/>
<person name="Jia C.Y."/>
<person name="Han V.K."/>
<person name="Li S.S."/>
</authorList>
<dbReference type="PubMed" id="12458214"/>
<dbReference type="DOI" id="10.1074/jbc.m206649200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SLAMF1; CD244; CD84 AND FYN</scope>
<scope>CHARACTERIZATION OF VARIANTS XLP1 CYS-7; PRO-99; LEU-101 AND GLY-102</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Nat. Cell Biol." volume="5" first="149" last="154">
<title>Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation.</title>
<authorList>
<person name="Latour S."/>
<person name="Roncagalli R."/>
<person name="Chen R."/>
<person name="Bakinowski M."/>
<person name="Shi X."/>
<person name="Schwartzberg P.L."/>
<person name="Davidson D."/>
<person name="Veillette A."/>
</authorList>
<dbReference type="PubMed" id="12545173"/>
<dbReference type="DOI" id="10.1038/ncb919"/>
</citation>
<scope>INTERACTION WITH FYN</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-89</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2011" name="Annu. Rev. Immunol." volume="29" first="665" last="705">
<title>SLAM family receptors and SAP adaptors in immunity.</title>
<authorList>
<person name="Cannons J.L."/>
<person name="Tangye S.G."/>
<person name="Schwartzberg P.L."/>
</authorList>
<dbReference type="PubMed" id="21219180"/>
<dbReference type="DOI" id="10.1146/annurev-immunol-030409-101302"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1999" name="Mol. Cell" volume="4" first="555" last="561">
<title>Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition.</title>
<authorList>
<person name="Poy F."/>
<person name="Yaffe M.B."/>
<person name="Sayos J."/>
<person name="Saxena K."/>
<person name="Morra M."/>
<person name="Sumegi J."/>
<person name="Cantley L.C."/>
<person name="Terhorst C."/>
<person name="Eck M.J."/>
</authorList>
<dbReference type="PubMed" id="10549287"/>
<dbReference type="DOI" id="10.1016/s1097-2765(00)80206-3"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.1 ANGSTROMS) OF 1-104</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="314" last="323">
<title>A 'three-pronged' binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome.</title>
<authorList>
<person name="Hwang P.M."/>
<person name="Li C."/>
<person name="Morra M."/>
<person name="Lillywhite J."/>
<person name="Muhandiram D.R."/>
<person name="Gertler F."/>
<person name="Terhorst C."/>
<person name="Kay L.E."/>
<person name="Pawson T."/>
<person name="Forman-Kay J.D."/>
<person name="Li S.-C."/>
</authorList>
<dbReference type="PubMed" id="11823424"/>
<dbReference type="DOI" id="10.1093/emboj/21.3.314"/>
</citation>
<scope>STRUCTURE BY NMR IN COMPLEX WITH SLAMF1</scope>
<scope>CHARACTERIZATION OF VARIANTS XLP1 CYS-7; ARG-28; ILE-53; ILE-68; PRO-99; LEU-101 AND GLY-102</scope>
<scope>MUTAGENESIS OF ARG-32</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2003" name="Nat. Cell Biol." volume="5" first="155" last="160">
<title>SAP couples Fyn to SLAM immune receptors.</title>
<authorList>
<person name="Chan B."/>
<person name="Lanyi A."/>
<person name="Song H.K."/>
<person name="Griesbach J."/>
<person name="Simarro-Grande M."/>
<person name="Poy F."/>
<person name="Howie D."/>
<person name="Sumegi J."/>
<person name="Terhorst C."/>
<person name="Eck M.J."/>
</authorList>
<dbReference type="PubMed" id="12545174"/>
<dbReference type="DOI" id="10.1038/ncb920"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1-104 IN COMPLEX WITH SLAMF1 AND FYN</scope>
<scope>MUTAGENESIS OF ARG-78</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1999" name="Hum. Genet." volume="105" first="501" last="505">
<title>SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients.</title>
<authorList>
<person name="Yin L."/>
<person name="Ferrand V."/>
<person name="Lavoue M.-F."/>
<person name="Hayoz D."/>
<person name="Philippe N."/>
<person name="Souillet G."/>
<person name="Seri M."/>
<person name="Giacchino R."/>
<person name="Castagnola E."/>
<person name="Hodgson S."/>
<person name="Sylla B.S."/>
<person name="Romeo G."/>
</authorList>
<dbReference type="PubMed" id="10598819"/>
<dbReference type="DOI" id="10.1007/s004390051137"/>
</citation>
<scope>VARIANT XLP1 THR-32</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2000" name="Blood" volume="96" first="3118" last="3125">
<title>Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.</title>
<authorList>
<person name="Sumegi J."/>
<person name="Huang D."/>
<person name="Lanyi A."/>
<person name="Davis J.D."/>
<person name="Seemayer T.A."/>
<person name="Maeda A."/>
<person name="Klein G."/>
<person name="Seri M."/>
<person name="Wakiguchi H."/>
<person name="Purtilo D.T."/>
<person name="Gross T.G."/>
</authorList>
<dbReference type="PubMed" id="11049992"/>
</citation>
<scope>VARIANTS XLP1 CYS-7; ARG-28; PRO-31; TRP-42; ILE-53; CYS-54; SER-87; PRO-99 AND GLY-102</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2000" name="J. Immunol." volume="165" first="3549" last="3553">
<title>Defective NK cell activation in X-linked lymphoproliferative disease.</title>
<authorList>
<person name="Benoit L."/>
<person name="Wang X."/>
<person name="Pabst H.F."/>
<person name="Dutz J."/>
<person name="Tan R."/>
</authorList>
<dbReference type="PubMed" id="11034354"/>
<dbReference type="DOI" id="10.4049/jimmunol.165.7.3549"/>
</citation>
<scope>VARIANT XLP1 LEU-55</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2001" name="Blood" volume="98" first="1268" last="1270">
<title>SH2D1A mutations in Japanese males with severe Epstein-Barr virus-associated illnesses.</title>
<authorList>
<person name="Sumazaki R."/>
<person name="Kanegane H."/>
<person name="Osaki M."/>
<person name="Fukushima T."/>
<person name="Tsuchida M."/>
<person name="Matsukura H."/>
<person name="Shinozaki K."/>
<person name="Kimura H."/>
<person name="Matsui A."/>
<person name="Miyawaki T."/>
</authorList>
<dbReference type="PubMed" id="11493483"/>
<dbReference type="DOI" id="10.1182/blood.v98.4.1268"/>
</citation>
<scope>VARIANTS XLP1 ASP-8; SER-27; TYR-33 AND VAL-49</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="36809" last="36816">
<title>Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients.</title>
<authorList>
<person name="Morra M."/>
<person name="Simarro-Grande M."/>
<person name="Martin M."/>
<person name="Chen A.S.-I."/>
<person name="Lanyi A."/>
<person name="Silander O."/>
<person name="Calpe S."/>
<person name="Davis J."/>
<person name="Pawson T."/>
<person name="Eck M.J."/>
<person name="Sumegi J."/>
<person name="Engel P."/>
<person name="Li S.-C."/>
<person name="Terhorst C."/>
</authorList>
<dbReference type="PubMed" id="11477068"/>
<dbReference type="DOI" id="10.1074/jbc.m101305200"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS XLP1 CYS-7; ARG-28; TRP-42; ILE-53; ILE-68; PRO-99; LEU-101 AND GLY-102</scope>
<scope>INTERACTION WITH CD244; SLAMF1; CD84 AND LY9</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2003" name="Biochemistry" volume="42" first="14885" last="14892">
<title>Disease-causing SAP mutants are defective in ligand binding and protein folding.</title>
<authorList>
<person name="Li C."/>
<person name="Iosef C."/>
<person name="Jia C.Y.H."/>
<person name="Gkourasas T."/>
<person name="Han V.K.M."/>
<person name="Li S.-C."/>
</authorList>
<dbReference type="PubMed" id="14674764"/>
<dbReference type="DOI" id="10.1021/bi034798l"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS XLP1 PRO-31; CYS-54; LEU-55 AND SER-87</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2003" name="Clin. Infect. Dis." volume="37" first="E136" last="E141">
<title>Fatal hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection in a patient with a novel mutation in the signaling lymphocytic activation molecule-associated protein.</title>
<authorList>
<person name="Halasa N.B."/>
<person name="Whitlock J.A."/>
<person name="McCurley T.L."/>
<person name="Smith J.A."/>
<person name="Zhu Q."/>
<person name="Ochs H."/>
<person name="Dermody T.S."/>
<person name="Crowe J.E. Jr."/>
</authorList>
<dbReference type="PubMed" id="14583885"/>
<dbReference type="DOI" id="10.1086/379126"/>
</citation>
<scope>VARIANT PRO-57</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2005" name="Hum. Mutat." volume="25" first="506" last="506">
<title>Characterization of a new disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease.</title>
<authorList>
<person name="Erdos M."/>
<person name="Uzvoelgyi E."/>
<person name="Nemes Z."/>
<person name="Toeroek O."/>
<person name="Rakoczi E."/>
<person name="Went-Suemegi N."/>
<person name="Suemegi J."/>
<person name="Marodi L."/>
</authorList>
<dbReference type="PubMed" id="15841490"/>
<dbReference type="DOI" id="10.1002/humu.9339"/>
</citation>
<scope>VARIANT XLP1 ASP-16</scope>
<scope>CHARACTERIZATION OF VARIANT XLP1 ASP-16</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2006" name="Int. Immunol." volume="18" first="1055" last="1065">
<title>Missense mutations in SH2D1A identified in patients with X-linked lymphoproliferative disease differentially affect the expression and function of SAP.</title>
<authorList>
<person name="Hare N.J."/>
<person name="Ma C.S."/>
<person name="Alvaro F."/>
<person name="Nichols K.E."/>
<person name="Tangye S.G."/>
</authorList>
<dbReference type="PubMed" id="16720617"/>
<dbReference type="DOI" id="10.1093/intimm/dxl039"/>
</citation>
<scope>VARIANTS XLP1 CYS-54; THR-84 AND SER-87</scope>
<scope>CHARACTERIZATION OF VARIANTS XLP1 CYS-54; THR-84 AND SER-87</scope>
</reference>
<comment type="function">
<text evidence="5 14 17 25">Cytoplasmic adapter regulating receptors of the signaling lymphocytic activation molecule (SLAM) family such as SLAMF1, CD244, LY9, CD84, SLAMF6 and SLAMF7. In SLAM signaling seems to cooperate with SH2D1B/EAT-2. Initially it has been proposed that association with SLAMF1 prevents SLAMF1 binding to inhibitory effectors including INPP5D/SHIP1 and PTPN11/SHP-2 (PubMed:11806999). However, by simultaneous interactions, recruits FYN which subsequently phosphorylates and activates SLAMF1 (PubMed:12458214). Positively regulates CD244/2B4- and CD84-mediated natural killer (NK) cell functions. Can also promote CD48-, SLAMF6 -, LY9-, and SLAMF7-mediated NK cell activation. In the context of NK cell-mediated cytotoxicity enhances conjugate formation with target cells (By similarity). May also regulate the activity of the neurotrophin receptors NTRK1, NTRK2 and NTRK3.</text>
</comment>
<comment type="subunit">
<text evidence="4 11 12 14 15 16 17 18">Interacts with NTRK1, NTRK2 and NTRK3 (By similarity). Interacts with CD84, CD244, LY9, SLAMF1 and FYN.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6983382">
<id>O60880</id>
</interactant>
<interactant intactId="EBI-1580565">
<id>Q9BZW8</id>
<label>CD244</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6983382">
<id>O60880</id>
</interactant>
<interactant intactId="EBI-1165705">
<id>P20963</id>
<label>CD247</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6983382">
<id>O60880</id>
</interactant>
<interactant intactId="EBI-742054">
<id>Q96D03</id>
<label>DDIT4L</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6983382">
<id>O60880</id>
</interactant>
<interactant intactId="EBI-12039345">
<id>Q9UBR4-2</id>
<label>LHX3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6983382">
<id>O60880</id>
</interactant>
<interactant intactId="EBI-2865388">
<id>Q969G2</id>
<label>LHX4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6983382">
<id>O60880</id>
</interactant>
<interactant intactId="EBI-1039152">
<id>P08581</id>
<label>MET</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6983382">
<id>O60880</id>
</interactant>
<interactant intactId="EBI-4315002">
<id>Q13291</id>
<label>SLAMF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6983382">
<id>O60880</id>
</interactant>
<interactant intactId="EBI-14058448">
<id>Q96DU3</id>
<label>SLAMF6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6983382">
<id>O60880</id>
</interactant>
<interactant intactId="EBI-603457">
<id>Q07912</id>
<label>TNK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6983382">
<id>O60880</id>
</interactant>
<interactant intactId="EBI-11994780">
<id>Q07912-2</id>
<label>TNK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15552052">
<id>O60880-1</id>
</interactant>
<interactant intactId="EBI-1642523">
<id>Q15052</id>
<label>ARHGEF6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15552052">
<id>O60880-1</id>
</interactant>
<interactant intactId="EBI-717515">
<id>Q14155</id>
<label>ARHGEF7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15552052">
<id>O60880-1</id>
</interactant>
<interactant intactId="EBI-1580565">
<id>Q9BZW8</id>
<label>CD244</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15552052">
<id>O60880-1</id>
</interactant>
<interactant intactId="EBI-4315002">
<id>Q13291</id>
<label>SLAMF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="24">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O60880-1</id>
<name>A</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O60880-2</id>
<name>B</name>
<sequence type="described" ref="VSP_004386"/>
</isoform>
<isoform>
<id>O60880-3</id>
<name>C</name>
<sequence type="described" ref="VSP_004387"/>
</isoform>
<isoform>
<id>O60880-4</id>
<name>D</name>
<sequence type="described" ref="VSP_004390"/>
</isoform>
<isoform>
<id>O60880-5</id>
<name>E</name>
<sequence type="described" ref="VSP_004388"/>
</isoform>
<isoform>
<id>O60880-6</id>
<name>F</name>
<sequence type="described" ref="VSP_004389"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="10">Expressed at a high level in thymus and lung, with a lower level of expression in spleen and liver. Expressed in peripheral blood leukocytes, including T-lymphocytes. Tends to be expressed at lower levels in peripheral blood leukocytes in patients with rheumatoid arthritis.</text>
</comment>
<comment type="disease" evidence="7 8 9 12 13 15 17 20 21 22 23">
<disease id="DI-00694">
<name>Lymphoproliferative syndrome, X-linked, 1</name>
<acronym>XLP1</acronym>
<description>A rare immunodeficiency characterized by extreme susceptibility to infection with Epstein-Barr virus (EBV). Symptoms include severe or fatal mononucleosis, acquired hypogammaglobulinemia, pancytopenia and malignant lymphoma.</description>
<dbReference type="MIM" id="308240"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="online information" name="SH2D1Abase">
<link uri="http://structure.bmc.lu.se/idbase/SH2D1Abase/"/>
<text>SH2D1A mutation db</text>
</comment>
<dbReference type="EMBL" id="AL023657">
<property type="protein sequence ID" value="CAA19222.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF073019">
<property type="protein sequence ID" value="AAC62631.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF072930">
<property type="protein sequence ID" value="AAC62630.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB586694">
<property type="protein sequence ID" value="BAJ19023.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF100539">
<property type="protein sequence ID" value="AAC79712.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF100540">
<property type="protein sequence ID" value="AAC79713.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF100541">
<property type="protein sequence ID" value="AAC79714.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF100542">
<property type="protein sequence ID" value="AAC79715.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF100543">
<property type="protein sequence ID" value="AAC79716.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK311911">
<property type="protein sequence ID" value="BAG34852.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR542031">
<property type="protein sequence ID" value="CAG46828.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR542043">
<property type="protein sequence ID" value="CAG46840.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL022718">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471107">
<property type="protein sequence ID" value="EAX11848.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471107">
<property type="protein sequence ID" value="EAX11849.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC020732">
<property type="protein sequence ID" value="AAH20732.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS14608.1">
<molecule id="O60880-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS48162.1">
<molecule id="O60880-4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001108409.1">
<molecule id="O60880-4"/>
<property type="nucleotide sequence ID" value="NM_001114937.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002342.1">
<molecule id="O60880-1"/>
<property type="nucleotide sequence ID" value="NM_002351.4"/>
</dbReference>
<dbReference type="PDB" id="1D1Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A/B/C/D=1-104"/>
</dbReference>
<dbReference type="PDB" id="1D4T">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.10"/>
<property type="chains" value="A=1-104"/>
</dbReference>
<dbReference type="PDB" id="1D4W">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=1-104"/>
</dbReference>
<dbReference type="PDB" id="1KA6">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-128"/>
</dbReference>
<dbReference type="PDB" id="1KA7">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-128"/>
</dbReference>
<dbReference type="PDB" id="1M27">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1-104"/>
</dbReference>
<dbReference type="PDBsum" id="1D1Z"/>
<dbReference type="PDBsum" id="1D4T"/>
<dbReference type="PDBsum" id="1D4W"/>
<dbReference type="PDBsum" id="1KA6"/>
<dbReference type="PDBsum" id="1KA7"/>
<dbReference type="PDBsum" id="1M27"/>
<dbReference type="SMR" id="O60880"/>
<dbReference type="BioGRID" id="110246">
<property type="interactions" value="25"/>
</dbReference>
<dbReference type="DIP" id="DIP-40768N"/>
<dbReference type="IntAct" id="O60880">
<property type="interactions" value="32"/>
</dbReference>
<dbReference type="MINT" id="O60880"/>
<dbReference type="STRING" id="9606.ENSP00000360181"/>
<dbReference type="BindingDB" id="O60880"/>
<dbReference type="ChEMBL" id="CHEMBL2321636"/>
<dbReference type="iPTMnet" id="O60880"/>
<dbReference type="PhosphoSitePlus" id="O60880"/>
<dbReference type="BioMuta" id="SH2D1A"/>
<dbReference type="jPOST" id="O60880"/>
<dbReference type="MassIVE" id="O60880"/>
<dbReference type="PaxDb" id="O60880"/>
<dbReference type="PeptideAtlas" id="O60880"/>
<dbReference type="PRIDE" id="O60880"/>
<dbReference type="ProteomicsDB" id="49642">
<molecule id="O60880-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="49643">
<molecule id="O60880-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="49644">
<molecule id="O60880-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="49645">
<molecule id="O60880-4"/>
</dbReference>
<dbReference type="ProteomicsDB" id="49646">
<molecule id="O60880-5"/>
</dbReference>
<dbReference type="ProteomicsDB" id="49647">
<molecule id="O60880-6"/>
</dbReference>
<dbReference type="Antibodypedia" id="30053">
<property type="antibodies" value="443 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="4068"/>
<dbReference type="Ensembl" id="ENST00000360027">
<molecule id="O60880-4"/>
<property type="protein sequence ID" value="ENSP00000353126"/>
<property type="gene ID" value="ENSG00000183918"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000371139">
<molecule id="O60880-1"/>
<property type="protein sequence ID" value="ENSP00000360181"/>
<property type="gene ID" value="ENSG00000183918"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000477673">
<molecule id="O60880-5"/>
<property type="protein sequence ID" value="ENSP00000477094"/>
<property type="gene ID" value="ENSG00000183918"/>
</dbReference>
<dbReference type="GeneID" id="4068"/>
<dbReference type="KEGG" id="hsa:4068"/>
<dbReference type="UCSC" id="uc004euf.6">
<molecule id="O60880-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4068"/>
<dbReference type="DisGeNET" id="4068"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000183918.15"/>
<dbReference type="GeneCards" id="SH2D1A"/>
<dbReference type="GeneReviews" id="SH2D1A"/>
<dbReference type="HGNC" id="HGNC:10820">
<property type="gene designation" value="SH2D1A"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000183918">
<property type="expression patterns" value="Tissue enriched (lymphoid)"/>
</dbReference>
<dbReference type="MalaCards" id="SH2D1A"/>
<dbReference type="MIM" id="300490">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="308240">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O60880"/>
<dbReference type="OpenTargets" id="ENSG00000183918"/>
<dbReference type="Orphanet" id="538931">
<property type="disease" value="X-linked lymphoproliferative disease due to SH2D1A deficiency"/>
</dbReference>
<dbReference type="PharmGKB" id="PA35728"/>
<dbReference type="eggNOG" id="KOG0565">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155920"/>
<dbReference type="HOGENOM" id="CLU_125532_1_0_1"/>
<dbReference type="InParanoid" id="O60880"/>
<dbReference type="KO" id="K07990"/>
<dbReference type="OMA" id="VYTYRLH"/>
<dbReference type="OrthoDB" id="1417830at2759"/>
<dbReference type="PhylomeDB" id="O60880"/>
<dbReference type="TreeFam" id="TF343096"/>
<dbReference type="PathwayCommons" id="O60880"/>
<dbReference type="Reactome" id="R-HSA-198933">
<property type="pathway name" value="Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"/>
</dbReference>
<dbReference type="SignaLink" id="O60880"/>
<dbReference type="BioGRID-ORCS" id="4068">
<property type="hits" value="2 hits in 499 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SH2D1A">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O60880"/>
<dbReference type="GeneWiki" id="SH2D1A"/>
<dbReference type="GenomeRNAi" id="4068"/>
<dbReference type="Pharos" id="O60880">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:O60880"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome X"/>
</dbReference>
<dbReference type="RNAct" id="O60880">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000183918">
<property type="expression patterns" value="Expressed in thymus and 136 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O60880">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O60880">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002250">
<property type="term" value="P:adaptive immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007267">
<property type="term" value="P:cell-cell signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0006968">
<property type="term" value="P:cellular defense response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0006959">
<property type="term" value="P:humoral immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0050860">
<property type="term" value="P:negative regulation of T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045954">
<property type="term" value="P:positive regulation of natural killer cell mediated cytotoxicity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050776">
<property type="term" value="P:regulation of immune response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd10400">
<property type="entry name" value="SH2_SAP1a"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000980">
<property type="entry name" value="SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036860">
<property type="entry name" value="SH2_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR017289">
<property type="entry name" value="SH2_prot_1A"/>
</dbReference>
<dbReference type="InterPro" id="IPR035876">
<property type="entry name" value="SH2D1A_SH2"/>
</dbReference>
<dbReference type="Pfam" id="PF00017">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037828">
<property type="entry name" value="SH2_p1A"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00401">
<property type="entry name" value="SH2DOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00252">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50001">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-1064">Adaptive immunity</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0727">SH2 domain</keyword>
<feature type="chain" description="SH2 domain-containing protein 1A" id="PRO_0000097722">
<location>
<begin position="1"/>
<end position="128"/>
</location>
</feature>
<feature type="domain" description="SH2" evidence="6">
<location>
<begin position="6"/>
<end position="104"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with FYN SH3 domain" evidence="5">
<location>
<begin position="67"/>
<end position="92"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="3">
<location>
<position position="89"/>
</location>
</feature>
<feature type="splice variant" description="In isoform E." id="VSP_004388" evidence="24">
<original>VYCLCVLYHGYIYTYRVSQTETGSWSAETAPGVHKRYFRKIKNLISAFQKPDQGIVIPLQYPVEKKSSARSTQGTTGIREDPDVCLKAP</original>
<variation>ITVTFIHTECPRQKQVLGVLSISEARSRHCNTSAVSS</variation>
<location>
<begin position="40"/>
<end position="128"/>
</location>
</feature>
<feature type="splice variant" description="In isoform C." id="VSP_004387" evidence="24">
<original>YHGYIYTYRVSQTETGSWSAETAPGVHKRYFRKIKNLISAFQKPDQGIVIPLQYPVEKKSSARSTQGTTGIREDPDVCLKAP</original>
<variation>QHLGYIKDISGK</variation>
<location>
<begin position="47"/>
<end position="128"/>
</location>
</feature>
<feature type="splice variant" description="In isoform F." id="VSP_004389" evidence="24">
<original>YHGYIYTYRVSQTETGSWSAETAPGVHKRYFRKIKNLISAFQKPDQGIVIPLQYPVEKKSSARSTQGTTGIREDPDVCLKAP</original>
<variation>ISEARSRHCNTSAVSS</variation>
<location>
<begin position="47"/>
<end position="128"/>
</location>
</feature>
<feature type="splice variant" description="In isoform B." id="VSP_004386" evidence="24">
<original>TAPGVHKRYFRKIKNLISAFQKPDQGIVIPLQYPVEKKSSARSTQGTTGIREDPDVCLKAP</original>
<variation>HFRSQIKA</variation>
<location>
<begin position="68"/>
<end position="128"/>
</location>
</feature>
<feature type="splice variant" description="In isoform D." id="VSP_004390" evidence="24">
<location>
<begin position="114"/>
<end position="116"/>
</location>
</feature>
<feature type="sequence variant" description="In XLP1; reduced protein stability and reduced affinity for SLAMF1, decreases interaction with FYN; dbSNP:rs1569527111." id="VAR_048005" evidence="9 12 15 17">
<original>Y</original>
<variation>C</variation>
<location>
<position position="7"/>
</location>
</feature>
<feature type="sequence variant" description="In XLP1." id="VAR_048006" evidence="13">
<original>H</original>
<variation>D</variation>
<location>
<position position="8"/>
</location>
</feature>
<feature type="sequence variant" description="In XLP1; abolishes interaction with SLAMF1." id="VAR_048007" evidence="21">
<original>G</original>
<variation>D</variation>
<location>
<position position="16"/>
</location>
</feature>
<feature type="sequence variant" description="In XLP1." id="VAR_048008" evidence="13">
<original>G</original>
<variation>S</variation>
<location>
<position position="27"/>
</location>
</feature>
<feature type="sequence variant" description="In XLP1; reduced protein stability." id="VAR_048009" evidence="9 12 15">
<original>S</original>
<variation>R</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="sequence variant" description="In XLP1; reduced protein stability and reduced affinity for SLAMF1 and FYN." id="VAR_048010" evidence="9 20">
<original>L</original>
<variation>P</variation>
<location>
<position position="31"/>
</location>
</feature>
<feature type="sequence variant" description="In XLP1; dbSNP:rs111033624." id="VAR_005612" evidence="7 23">
<original>R</original>
<variation>T</variation>
<location>
<position position="32"/>
</location>
</feature>
<feature type="sequence variant" description="In XLP1." id="VAR_048011" evidence="13">
<original>D</original>
<variation>Y</variation>
<location>
<position position="33"/>
</location>
</feature>
<feature type="sequence variant" description="In XLP1; loss of interaction with CD84 and reduced affinity for SLAMF1." id="VAR_048012" evidence="9 12">
<original>C</original>
<variation>W</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="sequence variant" description="In XLP1." id="VAR_048013" evidence="13">
<original>G</original>
<variation>V</variation>
<location>
<position position="49"/>
</location>
</feature>
<feature type="sequence variant" description="In XLP1; loss of interaction with CD84; loss of interaction with non-phosphorylated SLAMF1." id="VAR_048014" evidence="9 12 15">
<original>T</original>
<variation>I</variation>
<location>
<position position="53"/>
</location>
</feature>
<feature type="sequence variant" description="In XLP1; reduced protein stability and reduced affinity for SLAMF1 and FYN." id="VAR_048015" evidence="9 20 22">
<original>Y</original>
<variation>C</variation>
<location>
<position position="54"/>
</location>
</feature>
<feature type="sequence variant" description="In XLP1; reduced affinity for SLAMF1 and FYN; dbSNP:rs111033630." id="VAR_018307" evidence="8 20">
<original>R</original>
<variation>L</variation>
<location>
<position position="55"/>
</location>
</feature>
<feature type="sequence variant" description="In one XLP1 patient; unknown pathological significance." id="VAR_048016" evidence="19">
<original>S</original>
<variation>P</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="sequence variant" description="In XLP1; loss of interaction with CD84; strongly reduced affinity for SLAMF1; dbSNP:rs111033627." id="VAR_005613" evidence="12 15 23">
<original>T</original>
<variation>I</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="sequence variant" description="In XLP1; reduced protein stability." id="VAR_048017" evidence="22">
<original>I</original>
<variation>T</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="sequence variant" description="In XLP1; reduced protein stability and reduced affinity for SLAMF1 and FYN." id="VAR_048018" evidence="9 20 22">
<original>F</original>
<variation>S</variation>
<location>
<position position="87"/>
</location>
</feature>
<feature type="sequence variant" description="In XLP1; reduced protein stability and strongly reduced affinity for SLAMF1, disrupts interaction with FYN." id="VAR_048019" evidence="9 12 15 17">
<original>Q</original>
<variation>P</variation>
<location>
<position position="99"/>
</location>
</feature>
<feature type="sequence variant" description="In XLP1; reduced protein stability and reduced affinity for SLAMF1, decreases interaction with FYN; dbSNP:rs111033626." id="VAR_005614" evidence="10 12 15 23">
<original>P</original>
<variation>L</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="sequence variant" description="In XLP1; reduced protein stability and strongly reduced affinity for SLAMF1, decreases interaction with FYN." id="VAR_048020" evidence="9 12 15 17">
<original>V</original>
<variation>G</variation>
<location>
<position position="102"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced affinity for SLAMF1." evidence="15">
<original>R</original>
<variation>Q</variation>
<location>
<position position="32"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with FYN." evidence="18">
<original>R</original>
<variation>E</variation>
<location>
<position position="78"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="5"/>
<end position="7"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="13"/>
<end position="23"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="28"/>
<end position="33"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="35"/>
<end position="37"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="41"/>
<end position="47"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="50"/>
<end position="58"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="64"/>
<end position="66"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="77"/>
<end position="79"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="80"/>
<end position="87"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="89"/>
<end position="96"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1D4T"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1KA6"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250"/>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O88890"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00191"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10598819"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11034354"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11049992"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11282995"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11389028"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11477068"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11493483"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11806999"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11823424"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12115647"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12458214"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12545174"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14583885"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14674764"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15841490"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16720617"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9771704"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000305"/>
<evidence key="25" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="21219180"/>
</source>
</evidence>
<sequence length="128" mass="14187" checksum="90234E7A6614EE3D" modified="1998-08-01" version="1">MDAVAVYHGKISRETGEKLLLATGLDGSYLLRDSESVPGVYCLCVLYHGYIYTYRVSQTETGSWSAETAPGVHKRYFRKIKNLISAFQKPDQGIVIPLQYPVEKKSSARSTQGTTGIREDPDVCLKAP</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

